ROLE OF OCT-ANGIOGRAPHY IN STUDYING OF PATHOGENESIS, DIAGNOSTICS AND MONITORING THE MACULAR TELANGIECTASIES IN CHILDREN
- Authors: Katargina L.A1, Denisova E.V1, Osipova N.A.1, Kogoleva L.V1, Tarasenkov A.O1, Belova M.V1, Novikova O.V1
-
Affiliations:
- The Helmholtz Moscow Research Institute of Eye Diseases of the Ministry of Health
- Issue: Vol 13, No 1 (2018)
- Pages: 21-25
- Section: Articles
- URL: https://journals.rcsi.science/1993-1859/article/view/39573
- DOI: https://doi.org/10.18821/1993-1859-2018-13-1-21-25
- ID: 39573
Cite item
Full Text
Abstract
Full Text
##article.viewOnOriginalSite##About the authors
L. A Katargina
The Helmholtz Moscow Research Institute of Eye Diseases of the Ministry of HealthMoscow, 105062, Russian Federation
E. V Denisova
The Helmholtz Moscow Research Institute of Eye Diseases of the Ministry of HealthMoscow, 105062, Russian Federation
Natal’ja A. Osipova
The Helmholtz Moscow Research Institute of Eye Diseases of the Ministry of Health
Email: natashamma@mail.ru
ophthalmologist of ophthalmology department (pediatric surgery) of The Helmholtz Moscow Research Institute of Eye Diseases of the Ministry of Health of the Russian Federation Moscow, 105062, Russian Federation
L. V Kogoleva
The Helmholtz Moscow Research Institute of Eye Diseases of the Ministry of HealthMoscow, 105062, Russian Federation
A. O Tarasenkov
The Helmholtz Moscow Research Institute of Eye Diseases of the Ministry of HealthMoscow, 105062, Russian Federation
M. V Belova
The Helmholtz Moscow Research Institute of Eye Diseases of the Ministry of HealthMoscow, 105062, Russian Federation
O. V Novikova
The Helmholtz Moscow Research Institute of Eye Diseases of the Ministry of HealthMoscow, 105062, Russian Federation
References
- Nowilaty S.R., Al-Shamsi H.N., Al-Khars W. Idiopathic juxtafoveolar retinal telangiectasis: a current review. Middle East Afr. J. Ophthalmol. 2010; 17: 224-41.
- Baz Ö., Yılmaz I., Alagöz C., Demircan A., Perente I., Özkaya A., Taşkapılı M. Efficacy of Intravitreal Bevacizumab in Treatment of Proliferative Type 2 Idiopathic Juxtafoveal Telangiectasia. Turk. J. Ophthalmol. 2017; 47: 144-8. doi: 10.4274/tjo.04874.
- Özkaya A., Yazıcı A.T., Demirok A. Jukstafoveal Telenjiektaziler. Ret.-Vit. 2012; 20: 13-21.
- Gass J.D., Blodi B.A. Idiopathic juxtafoveolar retinal telangiectasis. Update of classification and follow-up study. Ophthalmology. 1993; 100(10): 1536-46.
- Yannuzzi L.A., Bardal A.M., Freund K.B., Chen K.J., Eandi C.M., Blodi B. Idiopathic macular telangiectasia. Arch. Ophthalmol. 2006; 124: 450-60.
- Wu L., Evans T., Arevalo J.F. Idiopathic macular telangiectasia type 2 (idiopathic juxtafoveolar retinal telangiectasis type 2A, Mac Tel 2). Surv. Ophthalmol. 2013; 58(6): 536-59.
- Nowilaty S.R., Al-Shamsi H.N., Al-Khars W. Idiopathic juxtafoveolar retinal telangiectasis: a current review. Middle East Afr. J. Ophthalmol. 2010; 17: 224-41.
- Park D.W., Schatz H., McDonald H.R., Johnson R.N. Grid laser photocoagulation for macular edema in bilateral juxtafoveal telangiectasis. Ophthalmology. 1997; 104: 1838-46.
- Alldredge C.D., Garretson B.R. Intravitreal triamcinolone for the treatment of idiopathic juxtafoveal telangiectasis. Retina. 2003; 23:113-6.
- Raza S., Toklu Y., Anayol M.A., Şimşek Ş., Özkan B., Altıntaş A.K. Comparison between efficacy of triamcinolone acetonide and bevacizumab in a case with type 2A idiopathic parafoveal telangiectasia. Turk. J. Ophthalmol. 2011; 41: 6-9.
- Roller A.B., Folk J.C., Patel N.M., Boldt H.C., Russell S.R., Abramoff M.D., Mahajan V.B. Intravitreal bevacizumab for treatment of proliferative and nonproliferative type 2 idiopathic macular telangiectasia. Retina. 2011; 31: 1848-55.
- Kashani A.H., Chen C.L., Gahm J.K., Zheng F., Richter G.M., Rosenfeld P.J., Shi Y., Wang R.K. Optical coherence tomography angiography: A comprehensive review of current methods and clinical applications. Prog. Retin. Eye Res. 2017; 60: 66-100. doi: 10.1016/j.preteyeres.2017.07.002.